What is the recommended dose of Ceftriaxone (Ceftriaxone) for a child weighing 21 kilograms (Kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for a 21 kg Child

For a child weighing 21 kg, the recommended dose of ceftriaxone is 50-75 mg/kg/day, which equals 1050-1575 mg per day, administered once daily or divided every 12-24 hours depending on the severity of infection. 1, 2

General Dosing Guidelines

  • For less severe infections, administer 50-75 mg/kg/day (1050-1575 mg for a 21 kg child) given once daily or divided every 12-24 hours 1
  • For severe infections including pneumonia, administer 50-100 mg/kg/day (1050-2100 mg for a 21 kg child) given once daily or divided every 12-24 hours 1
  • The total daily dose should not exceed 2 grams for most infections in pediatric patients 2
  • For bacterial meningitis, administer 100 mg/kg/day (2100 mg for a 21 kg child) divided every 12-24 hours, with a maximum of 4 g daily 1, 2

Indication-Specific Dosing

Skin and Skin Structure Infections

  • 50-75 mg/kg/day (1050-1575 mg for a 21 kg child) given once daily or in equally divided doses twice a day 2
  • Total daily dose should not exceed 2 grams 2

Acute Otitis Media

  • Single intramuscular dose of 50 mg/kg (1050 mg for a 21 kg child), not to exceed 1 gram 2

Serious Infections (Other than Meningitis)

  • 50-75 mg/kg/day (1050-1575 mg for a 21 kg child) divided every 12 hours 2
  • Total daily dose should not exceed 2 grams 2

Meningitis

  • Initial therapeutic dose of 100 mg/kg (2100 mg for a 21 kg child), not to exceed 4 grams 2
  • Maintenance dose of 100 mg/kg/day (2100 mg for a 21 kg child), not to exceed 4 grams daily 2
  • May be administered once daily or in equally divided doses every 12 hours 2
  • Usual duration of therapy is 7-14 days 2

Pathogen-Specific Considerations

  • For Streptococcus pneumoniae with penicillin MIC <2.0 μg/mL: 50-100 mg/kg/day every 12-24 hours 3
  • For penicillin-resistant Streptococcus pneumoniae (MIC ≥4.0 μg/mL): 100 mg/kg/day every 12-24 hours 3
  • For Haemophilus influenzae (β-lactamase producing): 50-100 mg/kg/day every 12-24 hours 3
  • For gram-negative enteric bacilli: 100 mg/kg/day divided every 12 hours or 80 mg/kg/day every 24 hours (up to 4 g daily) 4

Administration Considerations

  • Intravenous administration should be given over a period of 30 minutes 2
  • For intramuscular administration, inject well within the body of a relatively large muscle 2
  • Reconstitute with appropriate diluent according to package instructions 2
  • Do not use diluents containing calcium, such as Ringer's solution or Hartmann's solution 2

Clinical Evidence Supporting Once-Daily Dosing

  • Studies have shown that once-daily administration of ceftriaxone (50-80 mg/kg) is effective for most serious bacterial infections in children with a clinical cure rate of 94% 5
  • The long half-life of ceftriaxone (average 4.2 hours in pediatric patients) supports once-daily dosing for most indications 6
  • For patients with estimated glomerular filtration rate >80 mL/min/1.73 m² or in areas with less-susceptible pathogens (MIC ≥0.5 mg/L), a twice-daily dosing regimen of 50 mg/kg may improve target attainment 7

Important Precautions

  • Ceftriaxone is contraindicated in neonates (≤28 days) if they require calcium-containing IV solutions due to risk of precipitation 2
  • Monitor for adverse effects, although they are generally mild and do not typically require discontinuation of therapy 5
  • For infections caused by Streptococcus pyogenes, therapy should be continued for at least 10 days 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.